Summary
This study investigates the bioactive constituents of Asparagus gracilis, a plant with ethnomedicinal relevance in South Asia, for their potential against Leishmania parasites. Isolated phytochemicals were subjected to molecular docking against putative Leishmania enzyme targets alongside in vitro antileishmanial screening, providing preliminary evidence for structure-activity relationships. The findings contribute to the search for plant-derived therapeutic leads against leishmaniasis, a neglected tropical disease of significant public health concern in endemic regions.
UK applicability
The findings have limited direct applicability to UK farming or food systems; however, they may be of interest to UK researchers working on neglected tropical diseases, phytotherapy, or natural product drug discovery, particularly given the UK's global health research commitments.
Key measures
IC50 values (antileishmanial activity); binding affinity scores (kcal/mol) from molecular docking; possibly cytotoxicity indices (CC50, selectivity index)
Outcomes reported
The study likely assessed the antileishmanial activity of compounds isolated from Asparagus gracilis through in vitro bioassays and evaluated their binding interactions with Leishmania target proteins via molecular docking simulations.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.